Page last updated: 2024-12-04

3-hydroxyanthranilic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Hydroxyanthranilic Acid: An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxyanthranilic acid : An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

3-hydroxyanthranilate : A hydroxybenzoate that is the conjugate base of 3-hydroxyanthranilic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86
CHEMBL ID445304
CHEBI ID15793
SCHEMBL ID88229
MeSH IDM0023218

Synonyms (74)

Synonym
smr000471838
MLS001066415
4-14-00-02071 (beilstein handbook reference)
1uqb1bt4ot ,
unii-1uqb1bt4ot
BRD-K27265817-001-01-4
3-oxyanthranilic acid
CHEBI:15793 ,
2-amino-3-hydroxy-benzoic acid
3-ohaa
3-hydroxy-anthranilsaeure [german]
hsdb 4040
einecs 208-962-5
ccris 4427
nsc 522891
ai3-52837
brn 0973356
NCGC00179794-01
OPREA1_735317
wln: zr bq fvq
2-amino-3-hydroxybenzoic acid ,
benzoic acid, 2-amino-3-hydroxy-
anthranilic acid, 3-hydroxy-
nsc-522891
nsc522891
3-hydroxy-anthranilsaeure
inchi=1/c7h7no3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9h,8h2,(h,10,11
3-HYDROXY-ANTHRANILATE ,
3-hydroxyanthranilate
548-93-6
C00632
3-hydroxyanthranilic acid
DB03644
1U1W
ACON1_002137
3-hydroxyanthranilic acid, 97%
6B30EFED-FCCC-46EA-A7A4-40DDB1804913
A0316
BMSE000321
anthranilic acid, 3-hydroxy- (8ci)
CHEMBL445304
3-oh-anthranilic acid
STK894860
A830395
HMS2231F22
S3355
FT-0615802
3-hydroxy anthranilic acid
AM20060669
AKOS015856349
2-amino-3-hydroxy-benzoic acid [hsdb]
HMS3373P15
SCHEMBL88229
SY030553
mfcd00007700
AC-23861
DTXSID40203290
CS-W001171
GS-4375
3-hydroxy-2-aminobenzoate
3-hydroxyantranilic acid
3-hydroxy-anthranilic acid
2-amino-3-hydroxy-benzoate
3-oxyanthranilate
3-hydroxanthranilate
3-hydroxy-2-aminobenzoic acid
HY-W001171
Q2823213
SB76097
2-amino-3-hydroxybenzoicacid
EN300-98786
PD006740
3-haa, 3-hana
Z1255485352

Research Excerpts

Overview

3-Hydroxyanthranilic Acid (3-HAA) is a tryptophan metabolite reported to have anti-inflammatory activity.

ExcerptReferenceRelevance
"3-Hydroxyanthranilic Acid (3-HAA) is a tryptophan metabolite reported to have anti-inflammatory activity."( Inhibition of LPS-induced inflammatory mediators by 3-hydroxyanthranilic acid in macrophages through suppression of PI3K/NF-κB signaling pathways.
Kwak, JH; Lee, K; Pyo, S, 2016
)
1.41
"3-Hydroxyanthranilic acid is an IDO downstream metabolite that can produce an important immune suppression."( Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages.
Alegre, E; Coma, MJ; Díaz-Lagares, A; García-Girón, C; González, A; López, AS, 2008
)
1.47

Toxicity

ExcerptReferenceRelevance
" Hydrogen peroxide with 3-HAT was more toxic to the bacteria."( Superoxide dismutase enhances the toxicity of 3-hydroxyanthranilic acid to bacteria.
Ishii, T; Iwahashi, H; Kido, R; Sugata, R, 1991
)
0.54
"The adverse effects of D-tryptophan and the possibility of it being a surrogate index for predicting adverse effects in rats were investigated."( The urinary ratio of 3-hydroxykynurenine/3-hydroxyanthranilic acid is an index to predicting the adverse effects of D-tryptophan in rats.
Fukuwatari, T; Ohno, T; Sano, M; Shibata, K, 2014
)
0.67

Bioavailability

ExcerptReferenceRelevance
" Bioavailability of tryptophan is an absolute requirement for proper cell functioning and synthesis of hormones, whereas its degradation products can cause cell death."( Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
Bugiani, M; Dijkhuis, A; Duitman, JW; Geeraerts, Z; Guo, L; Lutter, R; Nossent, EJ; Roos, E; Schurink, B; van der Valk, P; van Vught, L; Vaz, FM; Vlaar, AP; Yeh, SR, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
"5 mg twice a week, the total dosage being 45-50 mg per mouse."( [Morphologic changes in the urinary bladder of mice induced by metabolites of tryptophan and tyrosine].
Raushenbakh, MO; Sergeeva, TI; Zharova, EI, 1976
)
0.26
" Cu (II) at increasing concentrations between 5μM and 20μM and in the presence of 100μM 3-OHAA showed an apparent dose-response in causing DNA strand breaks."( Comparative genotoxicity of 3-hydroxyanthranilic acid and anthranilic acid in the presence of a metal cofactor Cu (II) in vitro.
Chung, KT; Gadupudi, GS, 2011
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
aminobenzoic acid
monohydroxybenzoic acidAny hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
Metabolism14961108
Amino acid and derivative metabolism250260
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism4485
Tryptophan catabolism1426
Tryptophan Metabolism1855
NAD Metabolism1435
Tryptophan degradation ( Tryptophan degradation )6454
Kynurenine pathway and links to cell senescence2024
tryptophan degradation via kynurenine016
NAD biosynthesis (from tryptophan)020
NAD biosynthesis II from tryptophan024
NAD biosynthesis II (from tryptophan)024
Biochemical pathways: part I0466
NAD+ biosynthetic pathways014

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency56.23410.631035.7641100.0000AID504339
thioredoxin reductaseRattus norvegicus (Norway rat)Potency79.43280.100020.879379.4328AID588456
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686979
isocitrate dehydrogenase 1, partialHomo sapiens (human)Potency50.11876.309627.099079.4328AID602179
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency20.59620.00419.984825.9290AID504444
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency39.81070.050127.073689.1251AID588590
DNA polymerase kappa isoform 1Homo sapiens (human)Potency56.23410.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium bergheiIC50 (µMol)40.78000.889021.028671.5000AID504765; AID540252; AID540269
glucose-6-phosphate 1-dehydrogenase isoform bHomo sapiens (human)IC50 (µMol)24.00008.870012.851817.8000AID504792
large T antigenBetapolyomavirus macacaeIC50 (µMol)20.09000.160024.9724100.0000AID1903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Phenazine biosynthesis protein phzFPseudomonas fluorescensKd1.40001.40001.40001.4000AID977611
recombinase AMycobacterium tuberculosis H37RvEC50 (µMol)5.76600.018023.2882287.6000AID434968; AID435010
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Caspase 6, apoptosis-related cysteine peptidaseHomo sapiens (human)AC501.59000.063611.235844.9700AID720632
replicative DNA helicaseMycobacterium tuberculosis H37RvAC50203.58500.057030.7482325.3000AID449749; AID449750
Caspase-7Homo sapiens (human)AC506.14000.371017.049168.4900AID743295
Caspase-9Homo sapiens (human)AC5070.00000.21400.62371.3400AID743293
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (36)

Processvia Protein(s)Taxonomy
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
response to hypoxiaCaspase-9Homo sapiens (human)
kidney developmentCaspase-9Homo sapiens (human)
response to ischemiaCaspase-9Homo sapiens (human)
apoptotic processCaspase-9Homo sapiens (human)
DNA damage responseCaspase-9Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageCaspase-9Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome cCaspase-9Homo sapiens (human)
protein processingCaspase-9Homo sapiens (human)
platelet formationCaspase-9Homo sapiens (human)
response to cobalt ionCaspase-9Homo sapiens (human)
response to estradiolCaspase-9Homo sapiens (human)
response to lipopolysaccharideCaspase-9Homo sapiens (human)
glial cell apoptotic processCaspase-9Homo sapiens (human)
cellular response to UVCaspase-9Homo sapiens (human)
signal transduction in response to DNA damageCaspase-9Homo sapiens (human)
positive regulation of apoptotic processCaspase-9Homo sapiens (human)
fibroblast apoptotic processCaspase-9Homo sapiens (human)
neuron apoptotic processCaspase-9Homo sapiens (human)
protein maturationCaspase-9Homo sapiens (human)
cellular response to dexamethasone stimulusCaspase-9Homo sapiens (human)
leukocyte apoptotic processCaspase-9Homo sapiens (human)
intrinsic apoptotic signaling pathwayCaspase-9Homo sapiens (human)
epithelial cell apoptotic processCaspase-9Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-9Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processCaspase-9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-9Homo sapiens (human)
protein bindingCaspase-9Homo sapiens (human)
enzyme activator activityCaspase-9Homo sapiens (human)
peptidase activityCaspase-9Homo sapiens (human)
SH3 domain bindingCaspase-9Homo sapiens (human)
protein kinase bindingCaspase-9Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-9Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic signaling pathwayCaspase-9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
mitochondrionCaspase-9Homo sapiens (human)
nucleusCaspase-9Homo sapiens (human)
cytosolCaspase-9Homo sapiens (human)
caspase complexCaspase-9Homo sapiens (human)
apoptosomeCaspase-9Homo sapiens (human)
protein-containing complexCaspase-9Homo sapiens (human)
cytosolCaspase-9Homo sapiens (human)
cytoplasmCaspase-9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (78)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID386223Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 25 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385975Inhibition of TCR-mediated PLCgamma 1 activity in human Jurkat cells by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385970Effect on LPS-induced NF-kappaB activation in BALB/c mouse bone marrow-derived dendritic cells by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385993Inhibition of IL4 production in transgenic BALB/c mouse TH2 cells at 10 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385980Inhibition of CD28-induced NF-kappaB activation in human Jurkat cells by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385977Inhibition of PKC-theta-induced NF-kappaB activation in HEK293 cells by luciferase reporter gene assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385992Inhibition of IL4 production in transgenic BALB/c mouse TH2 cells at 50 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386215Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385962Inhibition of TCR-mediated JNK1 activation in transgenic BALB/c mouse TH2 cells at 100 uM by in vitro kinase assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385986Inhibition of IFN-gamma production in transgenic TH1 cells at 100 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385964Inhibition of TCR-mediated NFAT activation in transgenic BALB/c mouse TH2 cells at 100 uM by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385983Inhibition of PDK1 phosphorylation in transgenic BALB/c mouse TH2 cells by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385985Inhibition of IFN-gamma production in transgenic TH1 cells at 500 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385973Inhibition of TCR-mediated IKK activity in human Jurkat cells after 30 mins by in vitro kinase assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385978Inhibition of Carma1-induced NF-kappaB activation in HEK293 cells by luciferase reporter gene assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386214Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385976Inhibition of TCR-mediated PKCtheta activity in human Jurkat cells by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385999Inhibition of IL13 production in transgenic BALB/c mouse TH2 cells at 100 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385995Inhibition of IL5 production in transgenic BALB/c mouse TH2 cells at 100 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385972Effect on LPS-induced IL12 production in BALB/c mouse bone marrow-derived dendritic cells after 48 hrs by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385967Inhibition of TCR-mediated ERK activation in human Jurkat cells at 100 uM by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386000Inhibition of IL13 production in transgenic BALB/c mouse TH2 cells at 50 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385996Inhibition of IL5 production in transgenic BALB/c mouse TH2 cells at 50 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386227Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 6 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386226Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 6 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386213Antiasthmatic activity in ovalbumin-challenged BALB/c mouse assessed as reduction in airway resistance at 100 ug, intratracheally administered 4 hrs after challenge2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386008Induction of apoptosis in human Jurkat cells after 48 hrs by FACS2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385965Inhibition of TCR-mediated NF-kappaB activation in human Jurkat cells at 100 uM by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386220Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 100 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385979Inhibition of Bcl10-induced NF-kappaB activation in HEK293 cells by luciferase reporter gene assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385982Inhibition of PDK1 phosphorylation in human Jurkat cells by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385991Inhibition of IL4 production in transgenic BALB/c mouse TH2 cells at 100 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385974Inhibition of TCR-mediated IkappaB degradation in human Jurkat cells after 30 mins by immunoblotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385963Inhibition of TCR-mediated ERK activation in transgenic BALB/c mouse TH2 cells at 100 uM by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385989Induction of apoptosis in transgenic TH1 cells after 48 hrs by FACS2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386010Antiasthmatic activity in ovalbumin-challenged BALB/c mouse assessed as reduction in airway hyperresponsiveness at 100 ug, intratracheally administered 4 hrs after challenge2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385971Effect on LPS-induced IL6 production in BALB/c mouse bone marrow-derived dendritic cells after 48 hrs by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386005Inhibition of IL10 production in transgenic BALB/c mouse TH2 cells at 10 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386224Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 25 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385981Inhibition of CD3/CD28-induced NF-kappaB activation in human Jurkat cells by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385987Inhibition of IFN-gamma production in transgenic TH1 cells at 50 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386229Antiasthmatic effect in ovalbumin-challenged transgenic TH2 cells transfected SCID mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 100 ug administered 4-6 hrs after challenge by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386219Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 100 ug2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386004Inhibition of IL10 production in transgenic BALB/c mouse TH2 cells at 50 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386225Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 6 ug2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385988Inhibition of IFN-gamma production in transgenic TH1 cells at 10 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386003Inhibition of IL10 production in transgenic BALB/c mouse TH2 cells at 100 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385984Inhibition of recombinant PDK1 autophosphorylation by in vitro kinase assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386001Inhibition of IL13 production in transgenic BALB/c mouse TH2 cells at 10 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385966Inhibition of TCR-mediated JNK1 activation in human Jurkat cells at 100 uM by in vitro kinase assay2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386006Antiproliferative activity in transgenic BALB/c mouse TH2 cells assessed as [3H]thymidine incorporation after 30 mins2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386009Induction of apoptosis in LPS-stimulated BALB/c mouse bone marrow-derived dendritic cells after 48 hrs by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385997Inhibition of IL5 production in transgenic BALB/c mouse TH2 cells at 10 uM after 48 hrs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386217Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in peribronchial eosinophil infiltration in bronchoalveolar lavage fluid2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386221Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 100 ug by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385969Effect on LPS-induced NF-kappaB activation in mouse RAW264.7 cells by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386218Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in perivascular eosinophil infiltration in bronchoalveolar lavage fluid2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386230Antiasthmatic effect in ovalbumin-challenged transgenic TH2 cells transfected SCID mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 100 ug administered 4-6 hrs after challenge by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385968Inhibition of TCR-mediated NFAT activation in human Jurkat cells at 100 uM by Western blotting2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386231Induction of apoptosis in ovalbumin-challenged transgenic BALB/c mouse TH2 cells transfected in SCID mouse assessed as decrease in viable cell in lungs2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID385961Inhibition of TCR-mediated NF-kappaB activation in transgenic BALB/c mouse TH2 cells at 100 uM by EMSA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386007Induction of apoptosis in transgenic BALB/c mouse TH2 cells after 48 hrs by FACS2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386216Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid by ELISA2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386228Antiasthmatic effect in ovalbumin-challenged transgenic TH2 cells transfected SCID mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 100 ug administered 4-6 hrs after challenge2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID386222Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 25 ug2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2004Proceedings of the National Academy of Sciences of the United States of America, Nov-23, Volume: 101, Issue:47
Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens.
AID1811Experimentally measured binding affinity data derived from PDB2004Proceedings of the National Academy of Sciences of the United States of America, Nov-23, Volume: 101, Issue:47
Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (327)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990138 (42.20)18.7374
1990's61 (18.65)18.2507
2000's49 (14.98)29.6817
2010's57 (17.43)24.3611
2020's22 (6.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.28 (24.57)
Research Supply Index5.87 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index43.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.57%)5.53%
Reviews11 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational3 (0.85%)0.25%
Other336 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]